chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bad headache; cold sweats; nausea; diarrhea; swollen glands; weird taste in the mouth; Could not lift arm at all; Pustule rash on forehead face and behind the ears; Soreness and hard at injection site 2 days post; Lots of fatigue for the first two weeks to the point where I wanted to fall asleep in traffic.; Soreness and hard at injection site 2 days post; This is a spontaneous report from a contactable healthcare professional, the patient. A 55-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO176) via an unspecified route of administration in the right arm on 30Apr2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), probiotics (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3), multivitamin (MANUFACTURER UNKNOWN) and others. The patient previously took cefdinir and experienced allergy to it. On 02May2021 at 12:00, he patient experienced pustule rash on forehead face and behind the ears two days post (until this week). The patient also experienced soreness and hard at injection site two days post vaccination, could not lift arm at all (five days post vaccination), weird taste in mouth (1 week post and ongoing until today), cold sweats, nausea, diarrhea and swollen glands (12 days post vaccination), bad headache (13 days post vaccination) with swollen glands, lots of fatigue (for the first two weeks to the point where the patient wanted to fall asleep in traffic).  Only thing at the time of report was weird taste is still off and on (NOT metallic). Therapeutic measures were not taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events pustular rash, soreness and hard at injection site, could not lift arm at all, weird taste in mouth, cold sweat, nausea, diarrhea, bad headache, swollen glands and fatigue was recovering at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 21May2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation.  Follow-up attempts completed. No further information is expected.
This spontaneous report was received from a healthcare worker (also reported as office manager) refers to multiple unspecified patients of unknown demographics. No relevant medical history of the patients was reported. On unspecified dates the multiple unspecified patients were vaccinated with (Oka/Merck) VARIVAX (strength, dose, route, site of administration and lot number were not reported). There were no concomitant medications reported. It was reported that the multiple unspecified patients were administered with (Oka/Merck) VARIVAX that was stored improperly on unknown dates. There were not adverse effects reported.  It was unspecified wether the patients had sought any medical attention. There was no product quality complaint involved.   Follow up information has been received from office manager, who stated she may call or fax information as it become available. Also reported that M-M-R II was not mentioned in the original call, but did experience a temperature excursion. No further information was available at that time.  Follow-up information as received from a healthcare professional refers to a 2 years of patient. On 11-JUN-2014 the patient was vaccinated with a dose of improperly stored M-M-R II (lot # reported as J011332, expiration date 13-SEP-2015) (strength, dose, route and site of administration were not reported).  This is one of several reports from the same reporter. Additional information has been requested.
feeling achy; This is a spontaneous report from a non-contactable consumer (patient) via medical information team. A 26-year-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if it was okay to take Tylenol or ibuprofen after the vaccine as she was feeling achy on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible. Information about batch/lot number cannot be obtained.
I got the first dose of the Pfizer covid-19 vaccine on 8/10/2021. I started my period on 8/12/2021 and have not had heavy periods outside of 5 days with cramping usually only lasting 2-3. I'm currently on the 6th day of my period and it is heavy with very painful cramping.
Severe chills - uncontrolled, full body; rapid onset and rise of fever - max approx 102 degrees. Woke at 12:30am, fever rose from 99.9 degrees at 1am to 102 degrees at 1:30am. Spoke with on-call nurse at 1am, discussed ER. Shivering/chills had subsided to more controlled level by 1:30am. Took sodium naproxen and decided to wait. Fever broke approx 2pm.
Maybe a half hour after my first moderna shot, i got ringing in my ears, and i wondered if it was from the vaccine, and started to feel very worried, but it went away after maybe an hour. After my second shot, it came back and it is worse and never goes away completely, and it gets worse if i am upset, or of course at night, though sometimes i do not percieve it, it always comes back. It is not like my normal tinnitus, it doesnt sound the same, it is more metalllic sounding , not a single tone like normal tinnitus, it is like a metallic chorus of ringing. and it comes with a sort of light buzzing dizzy feeling. it is very upsetting. Still here after 2 months, i deeply hope it goes away. I checked the none of the above box, but i honestly dont know if this is permanent damage. If it is, as a musician, flute maker, and audio engineer that would be very bad for me.
Severe anxiety, malaise, weakness, uncontrollable shivering, pain at injection site, urinary retention.
polymyalgia rheumatica; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown  age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. In or around 01-OCT-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, frequency, lot # and expiration date were not reported) for routine health maintenance and for it's intended purpose the prevention of shingles (herpes zoster). On an unspecified date, shortly after receiving zoster vaccine live (ZOSTAVAX), Plaintiff suffered an abrupt onset of arthralgias and myalgias with aching, burning, excruciating and intermittent pain located in shoulders, hips, and knees bilaterally. Plaintiff was diagnosed with polymyalgia rheumatica. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), Plaintiff's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). Plaintiff also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result Plaintiff sustained severe and permanent personal injuries. Plaintiff suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Defendants' conduct, Plaintiff has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  Upon internal review, polymyalgia rheumatica was determined to be medically significant.
After vaccination went to observation area and after two to three minutes became light headed.  Remained light headed for one hour.  Felt like he was, "Mildly high."  Staff responded and provided assistance.  VS WNL.
The ones on my right are still noticeable but have; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (The ones on my right are still noticeable but have) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (The ones on my right are still noticeable but have). At the time of the report, LYMPHADENOPATHY (The ones on my right are still noticeable but have) outcome was unknown.            Concomitant product was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-224959 (Patient Link).
Pain in shoulder starting on 10/30/19 causing pain at all times . Sent for a PT and ortho evaluation and diagnosed with Bursitis, impingement in the rotator cuff area, tendonitis are all presenting the same symptoms. Treated with PT starting in December and ongoing to the present.
chills, muscle tightness, fatigue, nausea, headache soaking in a warm bath helped significantly It began 10:30 pm 3/26, lasted all day and night 3/27, and was gone when I woke up 3/28.
C/o weakness 15 mins after vaccination, the weakness went on x 1 day and half. Stated feel OK after that. October 28, 2009 Caller took the H1N1 vaccination shot yesterday. She has been feeling weak, unsure if related to shot. She has a history of panic attacks. She has no known allergies. She has been feeling weak since yesterday. Taking it easy laying in bed. Informed h/a, fever or weakness, generalized symptoms are common effects to the vaccine and should resolve in 2-4 days. Can treat the symptoms and if persistent hcf.
22SEP95 pt had fever 102.7;evening 22SEP95 when pt was put to bed became blue & wasn't breathing; grandma gave pt 5 breaths & stated pt had a sz then started breathing; EMS called but pt was not transported; pt seen by 25SEP95;
I have been itchy like hives; I have been itchy like hives; ears started itching and ringing; Anaphylactic reaction; ears started itching and ringing; my ears are burning; my throat was irritated/sore throat; Sore throat; This is a spontaneous report from a contactable nurse. A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: FF2587), via an unspecified route of administration, in right deltoid on 27Sep2021 17:30 (at the age of 58-years-old) as dose 1, single for COVID-19 immunization. Medical history was reported as none. Concomitant medication included moxifloxacin hydrochloride (AVELOX). The patient experienced anaphylactic reaction, ears started itching and ringing, ears are burning, my throat was irritated /sore throat, itchy like hives, ears started itching and ringing on 27Sep2021 18:00, i have been itchy like hives on an unspecified date. The patient was hospitalized for the events. Therapeutic measures were taken as a result of the events included Benadryl, Medrol pack and prednisolone. The outcome of the events was unknown.; Sender's Comments: Based on available information and a possible contributory role of suspect product BNT162B2 to the development of events anaphylactic reaction, tinnitus, ear discomfort, throat irritation, oropharyngeal pain, urticaria and pruritus cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Received vaccine on 1/23/21 and has been experiencing fairly intense vertigo since 1/24/21
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:1/12/2021.pfizer Lot#EL3248 2nd dose:02/02/21.pfizerLot#EN5318 Diagnosed covid positive: 03/16/21 Exposure:Home Exposure Symptoms:Asymptomatic
pt recv vax 28DEC98 & mom c/o congestion & lt leg swelling;noticed pt was congested;swelling on leg from DTAP site;swelling has gone down by using warm cloths to area;
Suspected vaccination failure; I know people that got vaccine and still git them; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I know people that got vaccine and still git them). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 22-JUN-2023 This case was reported by a consumer via interactive digital media. The reporter stated that it had been 2.5 years now.  The reporter knew people that got shingles vaccine and still got shingles.  They were the worst thing he/she ever had.  The reporter further stated that it felt like ground glass being continuously grounded into your skin and on shoulder and up side of neck.  The reporter wanted to know when his/her body temperature went up they burnt like mad.  The reporter further stated that lots of praying for them to be gone. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Vaccine administered within 20 min mm returned with child left arm showed induration with noticeable itching. Prescribed HC 2.5%.
This spontaneous report as received from a physician via other consumer refers to unspecified number of patients of unknown age and gender (however reported as "especially girls"). On an unknown date the patiens were vaccinated with GARDASIL (dose, route, lot # not reported). On an unknown date the patients experienced adverse reactions after receiving GARDASIL. The outcome of the adverse reactions was unknown. Relatedness between adverse reactions and GARDASIL was not specified. This is one of several reports received from the same reporter. Additional information has been requested.
Extremes welling at injection site and entire arm, reaching axillary area. Shoulder pain,
Shortly after receiving the second dose of the Pfizer vaccine, I began experiencing head aches and I developed a red inflamed eczema /open sore in my right arm pit that will not go away.
I started getting a funny feeling in my chest and a sore throat on Thursday, November 25th within about 12 to 18 hours of getting my COVID vaccination booster.  I thought it was related to the booster but after the other side effects went away, this feeling remained.  It seemed to be a cold that I had for about 2 and 1/2 weeks until it seemed to turn into a sinus infection. I waited one week to go see the doctor  at a local  oncall facility who said it was a sinus infection tested me for COVID,  and gave me an antibiotic.  I can't remember it's name right now.  A week later I went to a doctor at my regular doctor's office,  because the sinus infection wasn't clearing up.  That doctor gave me 7 days of doxycycline and by day four I was having vertigo.  On day 6, I called a local physical therapy place that works with vestibular issues and got a exam that day.  I have been going to PT since then 3 days a week.  I've gone seven times.  The issue seems to have started because of the strong antibiotic I was given and it also may stem from some issues within my neck that I already had. The cold seems to be lingering but it seems like the infection has cleared up. I was told that the vertigo is going to take at least four to six weeks to see some improvement because of the type of vertigo that it is.    I personally don't think that the vaccination had anything to do with the cold, sinus infection or vertigo but it was weird that the cold and the  COVID booster symptoms started on the same day.   I believe the vertigo was what I was referring to as the health incident in my vsafe check in because it made it so that I could not work for at least a week.
my nose was significantly swollen; This is a spontaneous report from a contactable other health professional (patient). A 27-year-old female patient (pregnant: No) received second dose of bnt162b2 (lot number: EK4176), intramuscular in left arm on 21Jan2021 09:00 at single dose for covid-19 immunization. Medical history included eczema from an unknown date and unknown if ongoing, GERD (gastrooesophageal reflux disease) from an unknown date and unknown if ongoing, allergies: Penicillin from an unknown date and unknown if ongoing, septorhinoplasty on 06Jan2021. Concomitant medication included fexofenadine hydrochloride (ALLEGRA), ibuprofen (MOTRIN), gummy multivitamin. The patient previously took azithromycin and experienced allergy. The patient previous received first dose of bnt162b2 (lot number: EK5730), intramuscular in left arm on 31Dec2020 09:15 AM at single dose for covid-19 immunization. The patient experienced her nose was significantly swollen on 22Jan2021 06:30. The adverse event was not resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. No treatment received for adverse event. The patient was a healthcare professional reporting her side effects after vaccine. She had a septorhinoplasty on 06Jan2021. Two weeks after her procedure, her nasal swelling significantly decreased. She returned to work and received her second vaccine on 21Jan2021 at 09:00. When she woke up on 22Jan2021 at 06:30, her nose was significantly swollen, which she believed to have been a reaction to the vaccine. No other breathing problems resulted. Facility type vaccine: Hospital. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The outcome of event was resolving.
First experienced itchiness everywhere on body on 11/23/2021. Woke up with hives on skin the next day. Hives were treated with Allegra medication, which worked for some time. Allegra stopped working after a few days. Presented to urgent care and was prescribed Prednisone and Vistaril. Medication was taken as prescribed but flares continued happening. Presented to general practitioner and was told it was just an allergy which caused urticaria. Developed a cough and runny nose with head sinus issues on  12/05/2021. Noticed on 12/08/2021 that the flare-ups could be induced by irritating the skin via scratching, which caused the spot on skin to be inflamed and raised with a red pigmentation (dermatographia or pressure urticaria).
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Apr2021 at 14:00 as dose 1, single (Lot number: EW0153), in right arm, on 27Apr2021 at 14:00 as dose 2, single (Batch/Lot number: unknown), in right arm and on 05Dec2021 at 14:00 as dose 3 (booster), single (Lot number: 33030BD) at the age of 47 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Thyroid disorder" (unspecified if ongoing); "long QT syndrome" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "depression" (unspecified if ongoing); "ADD" (unspecified if ongoing); "restless leg syndrome" (unspecified if ongoing); "overweight" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: MOBIC, start date: 01Jan2016; SYNTHROID, start date: 01Jan2016; CYTOMEL, start date: 01Jan2016; TRAZODONE, start date: 01Jan2016; LAMICTAL, start date: 01Jan2016; PROPRANOLOL, start date: 01Jan2016; BUSPAR, start date: 01Jan2016; ADDERALL, start date: 01Jan2016. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (23Oct2022) positive, notes: I took 2 antigen self tests, and both came back positive; (23Oct2022) Positive, notes: I took 2 antigen self tests, and both came back positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient received other medications in 2 weeks started in 01Jan2016. Patient received treatment for covid-19 which was Paxlovid from 14oct2022 to 19oct2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This is 1 of 4 pt to exp adverse rxn from this site. Pt exp inj site rxn of redness. No further info
While injecting IM Prevnar, felt small amount of solution under finger about an inch away from injection site like the solution leaked out of the muscle.  The next day the mom called and stated that the leg was swollen and red about an inch from the injection site.  No pain or fever.  Mom instructed to use cold compresses the first day and alternate cold and warm compresses the second day and also to check in with her doctor.
A report has been received from a Health Professional concerning a 9 year old, female patient. No information was provided regarding relevant history, concurrent diseases and concomitant medications of the patient. The patient has been receiving nasal FLUMIST Quadrivalent started on 09-NOV-2014. The reporter stated that the patient who received FLUMIST Quadrivalent at her office had come back with flu like symptoms, they were tested for Influenza A and the test result was positive. The patient was diagnosed with influenza A and was treated with TAMIFLU. At the time of reporting, the event of both patients were diagnosed with influenza was improving. The report was considered to be non-serious by company physician.
sinus drainage; Watery Eyes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus drainage) and LACRIMATION INCREASED (Watery Eyes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinus drainage) and LACRIMATION INCREASED (Watery Eyes). At the time of the report, SINUSITIS (sinus drainage) and LACRIMATION INCREASED (Watery Eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment medications information were not reported.